Veradermics, Inc SEC EDGAR Filings (CIK 0001827635)

SEC EDGAR filings, ownership reports, and insider transactions for Veradermics, Inc.

Symbol
MANE on NYSE
Industry
Pharmaceutical Preparations (Office Of Life Sciences)
Business address
470 James Street, New Haven, CT, 06513
State of incorporation
DE
Fiscal year end
31 December
⭐ Add to watchlist ⭐
Get insider transactions for this issuer
Veradermics, Inc has filed 48 SEC EDGAR filings since 09 Oct 2020

Latest Filings

Recent SEC filings for Veradermics, Inc including 4/A, SCHEDULE 13D, SCHEDULE 13G and more.

Form type Document Filing Description Filing date Reporting date File number(s)
4/A Open 4/A document View SEC filing for 4/A FORM 4/A 27 Feb 2026 03 Feb 2026
SCHEDULE 13D Open SCHEDULE 13D document View SEC filing for SCHEDULE 13D 12 Feb 2026 005-95484
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 12 Feb 2026 005-95484
SCHEDULE 13D Open SCHEDULE 13D document View SEC filing for SCHEDULE 13D 11 Feb 2026 005-95484
SCHEDULE 13D Open SCHEDULE 13D document View SEC filing for SCHEDULE 13D 11 Feb 2026 005-95484
4 Open 4 document View SEC filing for 4 09 Feb 2026 04 Feb 2026
3 Open 3 document View SEC filing for 3 09 Feb 2026 04 Feb 2026
4 Open 4 document View SEC filing for 4 4 05 Feb 2026 03 Feb 2026
4 Open 4 document View SEC filing for 4 FORM 4 05 Feb 2026 03 Feb 2026
4 Open 4 document View SEC filing for 4 FORM 4 05 Feb 2026 03 Feb 2026
4 Open 4 document View SEC filing for 4 FORM 4 05 Feb 2026 03 Feb 2026
4 Open 4 document View SEC filing for 4 FORM 4 05 Feb 2026 03 Feb 2026
4 Open 4 document View SEC filing for 4 FORM 4 05 Feb 2026 05 Feb 2026
4 Open 4 document View SEC filing for 4 FORM 4 05 Feb 2026 03 Feb 2026
4 Open 4 document View SEC filing for 4 FORM 4 05 Feb 2026 03 Feb 2026
4 Open 4 document View SEC filing for 4 FORM 4 05 Feb 2026 03 Feb 2026
4 Open 4 document View SEC filing for 4 FORM 4 05 Feb 2026 03 Feb 2026
4 Open 4 document View SEC filing for 4 FORM 4 05 Feb 2026 03 Feb 2026
4 Open 4 document View SEC filing for 4 FORM 4 05 Feb 2026 03 Feb 2026
S-8 Open S-8 document | Open XBRL data View SEC filing for S-8 S-8 05 Feb 2026 333-293238
8-K Open 8-K document View SEC filing for 8-K 8-K 05 Feb 2026 05 Feb 2026 001-43097
424B4 Open 424B4 document View SEC filing for 424B4 424B4 04 Feb 2026 333-292657
CERT Open CERT document View SEC filing for CERT NYSE CERTIFICATION 04 Feb 2026 001-43097
3 Open 3 document View SEC filing for 3 3 03 Feb 2026 03 Feb 2026
3 Open 3 document View SEC filing for 3 FORM 3 03 Feb 2026 03 Feb 2026
3 Open 3 document View SEC filing for 3 FORM 3 03 Feb 2026 03 Feb 2026
3 Open 3 document View SEC filing for 3 FORM 3 03 Feb 2026 03 Feb 2026
3 Open 3 document View SEC filing for 3 FORM 3 03 Feb 2026 03 Feb 2026
3 Open 3 document View SEC filing for 3 FORM 3 03 Feb 2026 03 Feb 2026
3 Open 3 document View SEC filing for 3 FORM 3 03 Feb 2026 03 Feb 2026
3 Open 3 document View SEC filing for 3 FORM 3 03 Feb 2026 03 Feb 2026
3 Open 3 document View SEC filing for 3 FORM 3 03 Feb 2026 03 Feb 2026
3 Open 3 document View SEC filing for 3 FORM 3 03 Feb 2026 03 Feb 2026
3 Open 3 document View SEC filing for 3 FORM 3 03 Feb 2026 03 Feb 2026
3 Open 3 document View SEC filing for 3 FORM 3 03 Feb 2026 03 Feb 2026
S-1MEF Open S-1MEF document | Open XBRL data View SEC filing for S-1MEF S-1MEF 03 Feb 2026 333-293180
8-A12B Open 8-A12B document View SEC filing for 8-A12B 8-A12B 03 Feb 2026 001-43097
FWP Open FWP document View SEC filing for FWP FWP 03 Feb 2026 333-292657
EFFECT Open EFFECT document View SEC filing for EFFECT 30 Jan 2026 333-292657
S-1/A Open S-1/A document | Open XBRL data View SEC filing for S-1/A S-1/A 28 Jan 2026 333-292657
S-1 Open S-1 document | Open XBRL data View SEC filing for S-1 S-1 09 Jan 2026 333-292657
D Open D document View SEC filing for D 28 Oct 2025 021-562294
DRS Open DRS document View SEC filing for DRS 27 Oct 2025 377-08614
D Open D document View SEC filing for D 10 Dec 2024 021-531652
D Open D document View SEC filing for D 01 May 2023 021-480424
D/A Open D/A document View SEC filing for D/A 07 Oct 2021 021-415905
D Open D document View SEC filing for D 06 Oct 2021 021-415905
D Open D document View SEC filing for D 09 Oct 2020 021-377538

About this filer

Veradermics, Inc files with the SEC under CIK 0001827635. This page aggregates EDGAR filings and related ownership activity.

Industry: Pharmaceutical Preparations.

See insider transactions for this issuer.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages